Science Abstracts
Treatment options for esophageal cancer
March 2010
March 2010
Authors : Thomas J Murphy1,2 , Narayamasamy Ravi1,2 , John V Reynolds1,2
Affliation :
1St James's Hospital, Department of Surgery, Trinity Centre, Dublin 8, Ireland ; reynoljv@tcd.ie
2Trinity College Dublin, Dublin 8, Ireland
DOI : 10.1517/14656560802560237
Published in : Expert Opin. Pharmacother.
Subject: Review
Keywords: adjuvant , cancer , 18FDG-PET , neoadjuvant , esophageal , randomized trials , tyrosine kinase inhibitors
Abstract
There is considerable controversy over the level...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Hopes high for Provenge to become first US-approved therapeutic cancer vaccine
- FDA panel backs InterMune's pulmonary fibrosis drug Esbriet despite reservations
- UK does not favour centralised EU-wide assessment of clinical trials
- FDA says ESAs need panel review for chronic kidney disease
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
